Abstract/Scope of Chapter
This chapter covers T and B lymphoblastic neoplasms, including acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LBL). Morphologic, immunophenotypic, and cytogenetic features are discussed along with the parameters of various modalities used in their diagnosis. The techniques and utility of minimum residual disease (MRD) measurement after therapy is discussed, as are new insights into the molecular biology of leukemogenesis gleaned from recent studies using gene expression profiling and copy number analysis via microarray techniques.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Borowitz MJ, Chan JKC. B lymphoblastic leukaemia/lymphoma, NOS, B lymphoblastic leukaemia/lymphoma with recurrent genetic abnormalities, and T lymphoblastic leukaemia/lymphoma. In: Swerdlow SH, Campo E, Harris NL, et al., eds. WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues. 4th ed. Lyon, France: International Agency for Research on Cancer, 2008:168-78.
Yeoh EJ, Ross ME, Shurtleff SA, et al. Classification, subtype discovery, and prediction of outcome in pediatric acute lymphoblastic leukemia by gene expression profiling. Cancer Cell 2002;1:133-43.
Mullighan CG, Su X, Zhang J, et al. Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia. N Engl J Med 2009;360:470-80.
Weng AP, Ferrando AA, Lee W, et al. Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia. Science 2004;306:269-71.
Ferrando AA, Neuberg DS, Staunton J, et al. Gene expression signatures define novel oncogenic pathways in T cell acute lymphoblastic leukemia. Cancer Cell 2002;1:75-87.
Schultz KR, Pullen DJ, Sather HN, et al. Risk- and response-based classification of childhood B-precursor acute lymphoblastic leukemia: a combined analysis of prognostic markers from the Pediatric Oncology Group (POG) and Children’s Cancer Group (CCG). Blood 2007;109:926-35.
Harrison CJ, Foront L. Cytogenetics and molecular genetics of acute lymphoblastic leukemia. Rev Clin Exp Hematol 2002;6:91-113.
Graux C, Cools J, Michaux L, et al. Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast. Leukemia 2006;20:1496-510.
Vega F, Medeiros LJ, Davuluri R, et al. t(8;13) positive bilineal lymphomas: report of 6 cases. Am J Surg Path 2008;32:14-20.
Yang JJ, Cheng C, Yang W. Genome-wide interrogation of germline genetic variation associated with treatment response in childhood acute lymphoblastic leukemia. JAMA 2009;301:393-403.
Rocha JC, Cheng C, Liu W. Pharmacogenetics of outcome in children with acute lymphoblastic leukemia. Blood 2005;105:4752-8.
Szczepanski T. Why and how to quantify minimum residual disease in acute lymphoblastic leukemia? Leukemia 2007;21:622-6.
Campana D. Determination of minimum residual disease in leukaemia patients. Br J Haematol 2003;121:823-38.
Campana D, Coustan-Smith E. Detection of minimal residual disease in acute leukemia by flow cytometry. Cytometry (Communications in Clinical Cytometry) 1999;38:139-52.
Chen W, Karandikar NJ, McKenna RW, Kroft SH. Stability of leukemia-associated immunophenotypes in precursor B-lymphoblastic leukemia/lymphoma: a single institution experience. Am J Clin Path 2007;127:39-46.
Neale GAM, Coustan-Smith E, Stow P, et al. Comparative analysis of flow cytometry and polymerase chain reaction for the detection of minimal residual disease in childhood acute lymphoblastic leukemia. Leukemia 2004;18:934-8.
Kohlmann A, Shoch C, Shnittger S, et al. Pediatric acute lymphoblastic leukemia (ALL) gene expression signatures classify an idependent cohort of adult ALL patients. Leukemia 2004;18:63-71.
Chiaretti S, Li X, Gentleman R, et al. Gene expression profiles of B-lineage adult acute lymphoblastic leukemia reveal genetic patterns that identify lineage derivation and distinct mechanisms of transformation. Clin Cancer Res 2005;11:7209-19.
Aifantis I, Raetz E, Buonamici S. Molecular pathogenesis of T-cell leukaemia and lymphoma. Nat Rev Immunol 2008;8:380-90.
Lin P, Jones D, Dorfman DM, Medeiros LJ. Precursor B-cell lymphoblastic lymphoma: a predominantly extranodal tumor with low propensity for leukemic involvement. Am J Surg Pathol 2000;24:1480-90.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Humana Press, a part of Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Sheehan, A.M. (2010). Lymphoblastic Leukemia and Lymphoma. In: Jones, D. (eds) Neoplastic Hematopathology. Contemporary Hematology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-384-8_13
Download citation
DOI: https://doi.org/10.1007/978-1-60761-384-8_13
Published:
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-60761-383-1
Online ISBN: 978-1-60761-384-8
eBook Packages: MedicineMedicine (R0)